{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-024951","form_type":"8-K","ticker":"HRGN","cik":"0001563665","company_name":"Harvard Apparatus Regenerative Technology, Inc.","filed_at":"2023-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.337849+00:00","generated_at":"2026-06-13T06:22:22.788657+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Biostage annual meeting: all four proposals pass, equity plan amended","bullets":["Junli He and James Shmerling elected as Class I directors; He received 10,377,115 'for' votes, Shmerling 2,345,415 'for' with 8,041,390 withheld.","Ratification of Marcum LLP as auditor for FY2023 approved: 11,763,540 for, 5,174 against, 473 abstentions.","Amendment to Amended and Restated Equity Incentive Plan to increase share reserve by 4,000,000 shares approved: 10,370,321 for, 16,358 against, 126 abstentions.","Non-binding advisory vote on executive compensation approved: 10,184,823 for, 12,603 against, 189,379 abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-024951","json":"https://secwatch.observer/filing/0001493152-23-024951.json","markdown":"https://secwatch.observer/filing/0001493152-23-024951.md","text":"https://secwatch.observer/filing/0001493152-23-024951.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223024951/0001493152-23-024951-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223024951/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T06:22:22.788657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1d793325de0b97d8b5757ccc3caf2f261097d31f","claim":"Harvard Apparatus Regenerative Technology, Inc. shareholders approved Approval of the amendment to the Company’s Amended and Restated Equity Incentive Plan to increase the number of shares of common stock available for issuance pursuant thereto by 4,000,000 shares at the 2023-07-19 meeting.","evidence_excerpt":"Proposal 3 – Approval of the amendment to the Company’s Amended and Restated Equity Incentive Plan The amendment to the Company’s Amended and Restated Equity Incentive Plan was approved as follows: Votes Non-Votes 10,370,321 16,358 126 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223024951/0001493152-23-024951-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-07-19"}],"fact_type":"shareholder_vote"},{"claim_id":"31db9c6077f123ef43c599cc794668783823d167","claim":"Harvard Apparatus Regenerative Technology, Inc. shareholders approved Non-binding approval of the compensation of the Company’s named executive officers at the 2023-07-19 meeting.","evidence_excerpt":"Proposal 4 – Approval, by Non-Binding Advisory Vote, of the Compensation of the Company’s Named Executive Officers The compensation of the Company’s named executive officers was approved, by a non-binding advisory vote, as follows: Votes Non-Votes 10,184,823 12,603 189,379 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223024951/0001493152-23-024951-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-07-19"}],"fact_type":"shareholder_vote"},{"claim_id":"7a1c162ee09db0a36c53371803f74d5230546c15","claim":"Harvard Apparatus Regenerative Technology, Inc. shareholders approved Ratification of the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-07-19 meeting.","evidence_excerpt":"Proposal 2 – Ratification of the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 The ratification of the appointment of Marcum LLP as the Company’s independent registered public accounting firm was approved as follows: Votes Non-Votes 11,763,540 5,174 473 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223024951/0001493152-23-024951-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-07-19"}],"fact_type":"shareholder_vote"},{"claim_id":"e0ab1824bee49aaf16510248eb356407f23c0802","claim":"Harvard Apparatus Regenerative Technology, Inc. shareholders approved Election of Directors at the 2023-07-19 meeting.","evidence_excerpt":"Proposal 1 - Election of Directors On such election of directors proposal, each of Junli He and Dr. James Shmerling were elected as Class I Directors, each for a three-year term, such term to continue until the annual meeting of stockholders in 2026 and until such Director’s successor is duly elected and qualified or until their earlier resignation or removal. Due to the plurality election, votes could only be cast in favor of or withheld from the nominee and thus votes against were not applicable. The results of the election were as follows: Name Votes Withheld Broker Non-Votes Junli He 10,377,115 9,690 1,382,382 James Shmerling 2,345,415 8,041,390 1,382,382","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223024951/0001493152-23-024951-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-07-19"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}